Brain Oscillatory Signatures of Auditory Stimuli Across Different Vigilance and Sedation States

March 22, 2023 updated by: University Hospital Inselspital, Berne

The investigators want to explore how presenting acoustic stimuli influences brain oscillatory signatures and heart rhythm- dynamics across different vigilance and sedation states.

The investigators will administer acoustic stimuli during sedation and anaesthesia while brain activity and heart activity are being recorded by electroencephalogram and electrocardiogram.

On the day following anaesthesia an optional nap/sleep period's EEG and ECG will be recorded. During this short sleep, patients will again be exposed to acoustic stimuli. The recorded EEG and ECG will be compared intra-and inter-individually to recordings from sedation and anaesthesia.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 84 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Informed Consent as documented by signature
  • Good general health status
  • Planned ophthalmic/plastic surgery at Inselspital Berne

Exclusion Criteria:

  • Contraindications on ethical grounds
  • Neurological/neurodegenerative disorder
  • Hearing problems (only if patients are not able to perceive the acoustic stimuli)
  • Pacemaker
  • Deep brain stimulator
  • Pregnancy
  • Known or suspected drug or alcohol abuse
  • Critical surgery procedure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Acoustic stimuli
Acoustic stimuli and comparison to within-subject baseline
During different states of sedation/anaesthesia and sleep, acoustic stimuli will be presented and compared to a within-subject baseline.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Brain oscillatory power derived by EEG
Time Frame: Continuously across anaesthesia/sedation/sleep up to 8 hours
Brain oscillatory response to acoustic stimuli derived by power spectral density in canonical frequency bands from 0.5 up to 40 Hz.
Continuously across anaesthesia/sedation/sleep up to 8 hours
Brain oscillatory response derived by Hilbert Amplitude
Time Frame: Continuously across anaesthesia/sedation/sleep up to 8 hours
Brain oscillatory response to acoustic stimuli derived by Hilbert-transforming EEG data and extracting Hilbert amplitude in microVolts
Continuously across anaesthesia/sedation/sleep up to 8 hours
Spindle characteristics - number of spindles
Time Frame: Continuously across anaesthesia/sedation/sleep up to 8 hours
Number of spindles
Continuously across anaesthesia/sedation/sleep up to 8 hours
Spindle characteristics - amplitude of spindles
Time Frame: Continuously across anaesthesia/sedation/sleep up to 8 hours
Spindle amplitude in microVolts
Continuously across anaesthesia/sedation/sleep up to 8 hours
Spindle characteristics - frequency of spindles
Time Frame: Continuously across anaesthesia/sedation/sleep up to 8 hours
Frequency of spindles in Hz
Continuously across anaesthesia/sedation/sleep up to 8 hours
Spindle characteristics - duration of spindles
Time Frame: Continuously across anaesthesia/sedation/sleep up to 8 hours
Duration of spindles in ms
Continuously across anaesthesia/sedation/sleep up to 8 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart rate
Time Frame: Continuously across anaesthesia/sedation/sleep up to 8 hours
Heart rate derived from echocardiogram in bpm
Continuously across anaesthesia/sedation/sleep up to 8 hours
Instantaneous heart rate
Time Frame: Continuously across anaesthesia/sedation/sleep up to 8 hours
Instantaneous heart rate derived from echocardiogram in bpm
Continuously across anaesthesia/sedation/sleep up to 8 hours
Heart rate variability
Time Frame: Continuously across anaesthesia/sedation/sleep up to 8 hours
Heart rate variability derived from echocardiogram in ms
Continuously across anaesthesia/sedation/sleep up to 8 hours
Slow wave characteristics - amplitude
Time Frame: Continuously across anaesthesia/sedation/sleep up to 8 hours
Slow wave amplitude in microVolt
Continuously across anaesthesia/sedation/sleep up to 8 hours
Slow wave characteristics - number
Time Frame: Continuously across anaesthesia/sedation/sleep up to 8 hours
Number of slow waves
Continuously across anaesthesia/sedation/sleep up to 8 hours
Slow wave characteristics - frequency
Time Frame: Continuously across anaesthesia/sedation/sleep up to 8 hours
Frequency of slow waves in Hz
Continuously across anaesthesia/sedation/sleep up to 8 hours
Slow wave characteristics - slope
Time Frame: Continuously across anaesthesia/sedation/sleep up to 8 hours
Slope of slow waves in microVolts/s
Continuously across anaesthesia/sedation/sleep up to 8 hours
Number of sleep arousals
Time Frame: Continuously across sleep up to 8 hours
Continuously across sleep up to 8 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Friedrich Lersch, University Hospital Inselspital, Berne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 28, 2023

Primary Completion (Anticipated)

November 1, 2023

Study Completion (Anticipated)

November 1, 2023

Study Registration Dates

First Submitted

March 1, 2023

First Submitted That Met QC Criteria

March 22, 2023

First Posted (Actual)

April 5, 2023

Study Record Updates

Last Update Posted (Actual)

April 5, 2023

Last Update Submitted That Met QC Criteria

March 22, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2022-00970 (Business Administration System for Ethics Committees (BASEC) number)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep

Clinical Trials on Acoustic stimuli

Subscribe